A Case for Small Cap Investing: Biotech

Dec 9, 2009

Emerald Life Sciences Team points out the key drivers behind small cap biotech performance and discusses it reasons for considering investing in small biotech stocks.


Related Files:

Professionals Login



Sign Up

Team Biographies

Meet Team Emerald: Team Bios

Team Emerald Snapshot

Inception

November 1991

Type of Business

Closely Held Corporation

Products

Investment Philosophy

Fundamental, Bottom-up Research Driven

Assets Under Management

$1.8 billion as of June 30, 2010